PubRank

Thomas Pabst

Author PubWeight™ 57.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009 4.90
2 Cytarabine dose for acute myeloid leukemia. N Engl J Med 2011 4.15
3 Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002 3.97
4 Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 2008 2.87
5 High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study. J Clin Oncol 2013 2.22
6 Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 2005 2.10
7 Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011 1.67
8 C/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006 1.60
9 ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2005 1.59
10 Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood 2007 1.53
11 Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol 2010 1.46
12 Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07). Leuk Lymphoma 2013 1.46
13 Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 2010 1.46
14 CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16). Blood 2005 1.34
15 Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. J Clin Oncol 2012 1.30
16 Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. J Clin Oncol 2012 1.28
17 Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2003 1.26
18 The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc Natl Acad Sci U S A 2004 1.22
19 Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 2009 1.18
20 Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatr Radiol 2012 1.18
21 The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood 2013 1.11
22 Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study. Blood 2010 1.07
23 Cardiac systolic rotation and contraction before and after valve replacement for aortic stenosis: a myocardial tagging study using MR imaging. AJR Am J Roentgenol 2002 1.05
24 Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML. Blood 2011 0.88
25 Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK). Blood 2012 0.86
26 The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients. Blood 2012 0.85
27 Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia. Sci Transl Med 2013 0.83
28 Pneumococcal vaccination in splenectomised cancer patients. Eur J Cancer 2005 0.83
29 Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Clin Cancer Res 2009 0.83
30 Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia. J Cell Mol Med 2009 0.83
31 Time course of 23Na signal intensity after myocardial infarction in humans. Magn Reson Med 2004 0.83
32 Heterozygous deletion of the PU.1 locus in human AML. Blood 2009 0.81
33 Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis. Blood 2011 0.79
34 Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy. Muscle Nerve 2010 0.79
35 Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Med Wkly 2013 0.78
36 Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency. Transfusion 2006 0.78
37 Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion 2014 0.78
38 Activation of the unfolded protein response in human acute myeloid leukemia. Methods Enzymol 2011 0.77
39 A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation. Swiss Med Wkly 2014 0.77
40 Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns. Eur J Radiol 2007 0.77
41 Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. Br J Haematol 2014 0.76
42 The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential. Leuk Res 2012 0.76
43 Time-resolved contrast-enhanced magnetic resonance angiography of the lower extremity. Angiology 2004 0.75
44 Cutaneous zygomycosis at catheter insertion site in AML-M4Eo. Ann Hematol 2006 0.75
45 Magnetic resonance imaging of the heart. Przegl Lek 2002 0.75
46 Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Leuk Lymphoma 2014 0.75
47 Pitfalls in the diagnosis of intravascular large B-cell lymphoma. Eur J Haematol 2013 0.75
48 Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia. Nutr Cancer 2013 0.75
49 Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Leuk Lymphoma 2012 0.75
50 Lineage-specific transcription factor aberrations in AML. Cancer Treat Res 2010 0.75